Listen up, pharma marketers--to patients' social media posts, that is
14 January 2016
Pharma companies are coming around on social media, however slowly. But how many are actually listening to what their patients say on social media platforms--and doing something with the feedback they get?
UK Pharmaceutical Companies Collaborate on CAR-T Cell Immuno-oncology Therapies
14 January 2016
Cell Therapy Catapult, University of Birmingham, and Cancer Research Technology announced on Jan. 6, 2016 the launch of a collaboration to develop a new immuno-oncology cellular therapy created modifying the genes of T-cells to target solid tumors.
Enhancing New Drug Development
14 January 2016
FDA once again approved more innovative new drugs this past year, beating a near record set in 2014. Yet, John Jenkins, director of the Office of New Drugs (OND) in The Center for Drug Evaluation and Research (CDER), is concerned if this pace of development will continue.
Biotechs launch an IPO blitz as Nasdaq stumbles out of the gate
13 January 2016
Nasdaq started off 2016 by stumbling out of the gate on Monday, taking a nasty hit along with the other major stock indexes as jitters about the Chinese market rattled investors once again. But 6 different biotechs shrugged off the chill that has afflicted industry stocks for months and filed IPOs which are collectively looking to raise hundreds of millions of dollars in the new year.
The biggest winners--and losers--in the 2015 race for new drug approvals
13 January 2016
In 2015, the FDA by its own account approved 45 new drugs, the largest one-year tally since 1996, which wrapped up with a record 53 regulatory OKs.
Japan's push on innovative drugs gets a budget boost
13 January 2016
Japan's cabinet gave the nod to a draft of next year's budget in a Christmas Eve meeting that saw the Ministry of Health, Labor and Welfare (MHLW) get funds outlined in September to promote development of innovative drugs and medical devices--and paves the way for compassionate clinical trial approvals.
FDA sends fewer drug promotion action letters in 2015--but is that a good thing for pharma?
13 January 2016
The downward trend continues for FDA action letters--but whether that's actually a good thing for the industry remains to be seen. In 2015, the OPDP issued just 9 letters, down from 10 the previous year. While the one-year drop is small, a further look back points to an ongoing decline since 2010, when there were 52 action letters sent. In the years between, there's been an annual decline in the number of letters. There were 31 sent in 2011; 28 in 2012 and 24 in 2013.
Hospitals respond to 'alarm fatigue' with patient monitoring innovation: WSJ
12 January 2016
Back in 2013, nonprofit hospital accreditor the Joint Commission set alarm safety for patient monitoring as its safety goal, giving hospitals until January 2016 to set up new policies and procedures for related devices. With the first of the year come and gone, healthcare centers are rolling out new solutions to reduce unnecessary alarms and improve monitoring.
Precision medicine plan in China may be announced in March
12 January 2016
The Chinese government is expected to announce a precision medicine initiative in March that could dwarf the $215 million U.S. plan announced last year.
Native advertising for pharma: Winning format or slippery slope to regulatory headaches?
12 January 2016
Did you see that ad? In many cases of native advertising, the answer is no--because people can't always tell what's an ad and what isn't. A study in the December Journal of Advertising found that the majority of consumers can't tell the difference between native advertising and editorial content. As more pharma marketers begin to embrace the format, and as the Federal Trade Commission continues to home in on native advertising for any deceptive practices, the findings are worth noting.
14 March 2024
26 February 2024
NovaMedica team wishes you a Merry Christmas and a Happy New Year!
26 December 2023
Putin has stated that Russia will support Africa in the struggle against epidemics
19 April 2024
The Russian government has expanded the list of vital and essential drugs
19 April 2024
Achieving FAIR bacterial identification
18 April 2024
Unique testing regimen could prevent nuclease contamination
18 April 2024